Completed NA INTERVENTIONAL 2-arm NCT02442323

A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients

Sponsor: Fox Chase Cancer Center

Updated 9 times since 2017 Last updated: Jan 2, 2021 Started: Aug 9, 2013 Primary completion: Aug 30, 2020 Completion: Nov 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02442323, this NA trial focuses on Cancer of Pancreas and remains completed. Sponsored by Fox Chase Cancer Center, it has been updated 9 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2021 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Feb 2021 [monthly]

Recruiting NA
Jul 2020 — Jan 2021 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Mar 2019 — Jul 2020 [monthly]

Recruiting NA
Jun 2018 — Mar 2019 [monthly]

Recruiting NA
Aug 2017 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fox Chase Cancer Center

Data source: Fox Chase Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States